Caroline Chevalier
Nessuna posizione attualmente
Storia della carriera di Caroline Chevalier
Precedenti posizioni note di Caroline Chevalier
Società | Posizione | Inizio | Fine |
---|---|---|---|
DECIPHERA PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | 01/01/2018 | 01/10/2021 |
TESARO INC | Ufficiale delle Risorse Umane | - | - |
Gestionova SAS
Gestionova SAS Miscellaneous Commercial ServicesCommercial Services Gestionova SAS operates as a holding company with interests in the provision of maintenance and building services. Through its subsidiaries, it offers solutions for air conditioning, heating, plumbing, waterproofing, and electricity. The company was founded on October 5, 1998 and is headquartered in Velizy-Villacoublay, France. | Corporate Officer/Principal | - | - |
Formazione di Caroline Chevalier
Boston College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Francia | 2 |
Posizioni
Human Resources Officer | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Gestionova SAS
Gestionova SAS Miscellaneous Commercial ServicesCommercial Services Gestionova SAS operates as a holding company with interests in the provision of maintenance and building services. Through its subsidiaries, it offers solutions for air conditioning, heating, plumbing, waterproofing, and electricity. The company was founded on October 5, 1998 and is headquartered in Velizy-Villacoublay, France. | Commercial Services |
Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Caroline Chevalier
- Esperienza